Prime Medicine (PRME) Earnings Date, Estimates & Call Transcripts → The new masters of energy (From Porter & Company) (Ad) Free PRME Stock Alerts $6.57 -0.32 (-4.64%) (As of 06/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (May. 10) -$0.44 Beat By $0.01 Consensus EPS (May. 10) -$0.45 Get Prime Medicine Earnings AlertsEnter your email address below to receive the latest news and earnings results for PRME and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePRME Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PRME Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingA New Generation of Billionaires Is About to Be CreatedOn June 30, AI will hit a tipping-point… $15.7 trillion of wealth is at stake. As many as 800 million jobs are caught in AI’s crosshairs…Click here for details. Prime Medicine Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.45)($0.45)($0.45)Q2 20242($0.45)($0.40)($0.43)Q3 20242($0.46)($0.40)($0.43)Q4 20242($0.42)($0.40)($0.41)FY 20247($1.78)($1.65)($1.72)Q1 20251($0.40)($0.40)($0.40)Q2 20251($0.40)($0.40)($0.40)Q3 20251($0.32)($0.32)($0.32)Q4 20251($0.32)($0.32)($0.32)FY 20254($1.44)($1.44)($1.44)PRME Earnings Date and InformationPrime Medicine last issued its earnings data on May 10th, 2024. The reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($0.45) by $0.01. The business earned $0.59 million during the quarter. Prime Medicine has generated ($2.17) earnings per share over the last year (($2.17) diluted earnings per share). Earnings for Prime Medicine are expected to grow in the coming year, from ($1.64) to ($1.47) per share. Prime Medicine has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More Prime Medicine Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024(Estimated)------- 5/10/2024Q1 2024($0.45)($0.44)+$0.01($0.44)-$0.59 million3/1/2024Q4 2023($0.48)($0.56)($0.08)($0.41)--11/3/2023Q3 2023($0.45)($0.55)($0.10)($0.55)--8/7/2023Q2 2023($0.42)($0.47)($0.05)($0.47)--5/11/2023Q1 2023($0.42)($0.44)($0.02)($0.44)--3/9/2023Q4 2022($0.77)($0.56)+$0.21($0.56)-- Get the Latest News and Ratings for PRME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. Prime Medicine Earnings - Frequently Asked Questions When is Prime Medicine's earnings date? Prime Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on PRME's earnings history. Did Prime Medicine beat their earnings estimates last quarter? In the previous quarter, Prime Medicine (NYSE:PRME) reported ($0.44) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.01. Learn more on analysts' earnings estimate vs. PRME's actual earnings. How much profit does Prime Medicine generate each year? Prime Medicine (NYSE:PRME) has a recorded net income of -$198.13 million. PRME has generated -$2.17 earnings per share over the last four quarters. What is Prime Medicine's EPS forecast for next year? Prime Medicine's earnings are expected to grow from ($1.64) per share to ($1.47) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Twist Bioscience Earnings Date Denali Therapeutics Earnings Date SpringWorks Therapeutics Earnings Date Arcellx Earnings Date Novavax Earnings Date Apogee Therapeutics Earnings Date ADMA Biologics Earnings Date CG Oncology Earnings Date Iovance Biotherapeutics Earnings Date Vericel Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NYSE:PRME) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prime Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.